Spin-freezing: the future of vaccine-drying?
Today, certain types of vaccines and products like diagnostics, therapeutics and foods are freeze-dried to inhibit spoilage, extend shelf life and increase access to these products in remote or low-resource settings.
For vaccines, a pioneering new technique, known as spin-freezing, could offer additional benefits to this traditional freeze-drying method for a more rapid and scaled-up response to future infectious disease outbreaks. To test its potential, CEPI is providing up to $1.9m to Ghent University to investigate how vaccines developed on the University’s specialised mRNA platform perform after spin-freezing.
CEPI’s Acting Executive Director of Vaccine Manufacturing and Supply Chain, Ingrid Kromann, explains: “In addition to making vaccines thermostable, spin-freezing has the potential to flip the usual batch production process utilised by pharmaceutical manufacturers and instead offer continuous manufacturing, which, if successful, could promote fast and flexible mRNA vaccine production.”
Project partners: RheaVita BV, VIB, Quantoom Biosciences
Find out more: https://lnkd.in/erPXHPK9